White Paper

Single Use Systems can make it easier for pharmaceutical manufacturers in terms of process operation and minimizing risk of contamination. Downtime can also be greatly reduced as SUS components are delivered ready for use, and are designed so that one component can quickly be interchanged with another, clean replacement, between runs or when changing to a different product on the same line.

SUS do however still pose challenges themselves, which need careful planning and consideration to maximize the benefit from them whilst ensuring patient safety and product integrity.

In this white paper we discuss some of the testing and validation considerations that pharmaceutical manufacturers should look at when implementing SUS, as well as other factors that can help them to optimise their usage.